Edward M. Barnett, MD, PhD

Publications

• Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization.

  (Qiu X, Gammon ST, Johnson JR, Pisaneschi F, Millward SW, Barnett EM, Piwnica-Worms D.) Biosensors (Basel). 2022 Aug 28;12(9) PMID: 36140078 PMCID: PMC9496076 SCOPUS ID: 2-s2.0-85138340626 09/24/2022

• Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.

  (Qiu X, Johnson JR, Wilson BS, Gammon ST, Piwnica-Worms D, Barnett EM.) PLoS One. 2014;9(2):e88855 PMID: 24586415 PMCID: PMC3931650 SCOPUS ID: 2-s2.0-84896784111 03/04/2014

• Optic nerve diffusion tensor imaging parameters and their correlation with optic disc topography and disease severity in adult glaucoma patients and controls.

  (Chang ST, Xu J, Trinkaus K, Pekmezci M, Arthur SN, Song SK, Barnett EM.) J Glaucoma. 2014;23(8):513-20 PMID: 23632406 PMCID: PMC3800509 SCOPUS ID: 2-s2.0-84916636627 05/02/2013

• Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model.

  (Johnson JR, Kocher B, Barnett EM, Marasa J, Piwnica-Worms D.) Bioconjug Chem. 2012 Sep 19;23(9):1783-93 PMID: 22900707 PMCID: PMC3447108 SCOPUS ID: 2-s2.0-84866370878 08/21/2012

• The incidence of retinal vein occlusion in the ocular hypertension treatment study.

  (Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group.) Ophthalmology. 2010 Mar;117(3):484-8 PMID: 20031222 PMCID: PMC3077045 SCOPUS ID: 2-s2.0-77049102378 12/25/2009

• VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans.

  (Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani H, Fukaya M, Watanabe M, Chang Q, Barnett EM, Swat W.) PLoS One. 2010 Feb 04;5(2):e9050 PMID: 20140222 PMCID: PMC2816215 SCOPUS ID: 2-s2.0-77949406694 02/09/2010

• Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

  (Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D.) Proc Natl Acad Sci U S A. 2009 Jun 09;106(23):9391-6 PMID: 19458250 PMCID: PMC2695102 SCOPUS ID: 2-s2.0-67249095097 05/22/2009

• An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging.

  (Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D.) Bioconjug Chem. 2009 Apr;20(4):702-9 PMID: 19331388 PMCID: PMC2672423 SCOPUS ID: 2-s2.0-65249177729 04/01/2009

• Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 23, (9391-9396) DOI: 10.1073/pnas.0812884106)

  (Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D.) Proceedings of the National Academy of Sciences of the United States of America. 14 July 2009;106(28):11819 SCOPUS ID: 2-s2.0-67650921940 07/14/2009

• Trabectome (trabeculectomy-internal approach): additional experience and extended follow-up.

  (Minckler D, Mosaed S, Dustin L, Ms BF, Trabectome Study Group.) Trans Am Ophthalmol Soc. 2008;106:149-59; discussion 159-60 PMID: 19277230 PMCID: PMC2646453 SCOPUS ID: 2-s2.0-62849090894 01/01/2008

• Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma.

  (Nolan MJ, Giovingo MC, Miller AM, Wertz RD, Ritch R, Liebmann JM, Allingham RR, Herndon LW, Wax MB, Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA.) J Glaucoma. 2007 Aug;16(5):419-29 PMID: 17700283 SCOPUS ID: 2-s2.0-34547912469 08/19/2007

• Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.

  (Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA, Ocular Hypertension Treatment Study Group.) Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3896-903 PMID: 16936102 PMCID: PMC1995656 SCOPUS ID: 2-s2.0-33749158039 08/29/2006